# Cardinal Health Inc: Form 10-Q for the period ended Sep 30, 2025

- Company: [Cardinal Health Inc](/companies/cah.md) (CIK 721371)
- Form: 10-Q
- Filed: 2025-10-30
- Accepted by EDGAR: Oct 30, 2025, 08:48 ET
- Period: 2025-09-30
- Accession: 0000721371-25-000130
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/721371/000072137125000130/cah-20250930.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/721371/000072137125000130/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2025-07-01 to 2025-09-30 | $64.01bn | us-gaap:Revenues |
| Cost of revenue | 3 months, 2025-07-01 to 2025-09-30 | $61.69bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2025-07-01 to 2025-09-30 | $2.32bn | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2025-07-01 to 2025-09-30 | $1.46bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2025-07-01 to 2025-09-30 | $668.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2025-07-01 to 2025-09-30 | $80.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2025-07-01 to 2025-09-30 | $144.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2025-07-01 to 2025-09-30 | $450.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2025-07-01 to 2025-09-30 | $1.88 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2025-07-01 to 2025-09-30 | $1.89 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2025-07-01 to 2025-09-30 | 239,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2025-07-01 to 2025-09-30 | $973.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2025-07-01 to 2025-09-30 | $108.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2025-07-01 to 2025-09-30 | $129.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months, 2025-07-01 to 2025-09-30 | $375.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2025-09-30 | $4.59bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2025-09-30 | $38.54bn | us-gaap:AssetsCurrent |
| Total assets | at 2025-09-30 | $55.23bn | us-gaap:Assets |
| Current liabilities | at 2025-09-30 | $40.27bn | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2025-09-30 | −$2.88bn | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/721371/000072137125000130/cah-20250930.htm

Filed Oct 30, 2025.
Source: SEC EDGAR, the filing index for accession 0000721371-25-000130. Last ingested by Listed: Nov 5, 2026, 12:30 ET. No prices; not investment advice.